课题基金 / 基金详情

项目摘要

项目成果

MARK G CLEMENS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In spite of many advances in liver transplant surgery, an increasing number of patients with terminal liver disease are dying while awaiting transplants. Consequently, further advances in the storage of donor livers, as well as alternative replacement options and mechanisms for supporting liver function while awaiting a donor liver are needed. A very promising area of research and development is in the development of engineered solutions to the problems of liver support for either natural donor organs or bioartificial livers. However, efforts undertaken within a single discipline are hampered by the complexity of both the engineering and biological aspects of such projects. This proposal constitutes a partnership between bioengineers, biologists and a liver transplant surgeon with the goal of combining their expertise to devise improved methods of liver support via bioartificial livers and improved preservation of donor livers via machine perfusion preservation (MPP). The partnership encompasses three inter-related projects. The first project focuses on delivery of oxygen and other nutrients to the cells in in vitro systems such as the bioartificial liver. The approach involves the modification of the support matrix to facilitate enhanced mass transport. The second project addresses the hypothesis that improved bioartificial liver function can be attained by providing a more physiological combination of cell types in the support device. Specifically, we will investigate the relationship between Kupffer cells and hepatocytes in maintaining prolonged hepatic-specific function in culture. The final project focuses on development of methods for optimization of microvascular perfusion in machine-perfused livers. This project uses a combination of intravital microscopy and mathematical modeling. In all of the projects, engineering and biological approaches, as well as clinical experience, are combined to address focused, clinically relevant problems. Moreover, the unique environment that supports the partnership will maximize the potential for success in this interdisciplinary approach and provide an avenue for potential clinical application of laboratory advances.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Engineering micropatterned surfaces for the coculture of hepatocytes and Kupffer cells.
用于肝细胞和枯否细胞共培养的微图案表面工程。
DOI: 10.1002/jbm.a.30399
发表时间: 2005
期刊: Journal of biomedical materials research. Part A.
影响因子: --
作者: [Zinchenko,YekaterinaS, Coger,RobinN]
通讯作者: Coger,RobinN
Optimizing normoxic conditions in liver devices using enhanced gel matrices.
使用增强型凝胶基质优化肝脏装置中的含氧量正常条件。
DOI: 10.1002/bit.21681
发表时间: 2008
期刊: Biotechnology and bioengineering
影响因子: 3.8
作者: [Niu,Mei, Clemens,MarkG, Coger,RobinN]
通讯作者: Coger,RobinN
Effects of enhanced O(2) transport on hepatocytes packed within a bioartificial liver device.
增强的 O(2) 运输对生物人工肝装置内肝细胞的影响。
DOI: 10.1089/107632704322791899
发表时间: 2004
期刊: Tissue engineering.
影响因子: --
作者: [McClelland,RandallE, Coger,RobinN]
通讯作者: Coger,RobinN
Antioxidant functionality in hepatocytes using the enhanced collagen extracellular matrix under different oxygen tensions.
在不同氧张力下使用增强的胶原细胞外基质的肝细胞抗氧化功能。
DOI: 10.1089/ten.2006.12.2825
发表时间: 2006
期刊: Tissue engineering
影响因子: --
作者: [Lee,Sang-Ho, Coger,RobinN, Clemens,MarkG]
通讯作者: Clemens,MarkG
Enhanced production of human hepatocytes from livers declined for transplant
  • 批准号:
    9140604
  • 项目类别:
  • 资助金额:
    $36.61万
  • 财政年份:
    2016
  • 负责人:
    MARK G CLEMENS
  • 依托单位:
Human hepatocytes for drug toxicity screening from Cardiac Death Donor livers
  • 批准号:
    8314669
  • 项目类别:
  • 资助金额:
    $36.13万
  • 财政年份:
    2012
  • 负责人:
    MARK G CLEMENS
  • 依托单位:
Regulation of sinusoidal perfusion in shock
Regulation of sinusoidal perfusion in shock